| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.44 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |